by Stephanie Wood Miller | Apr 30, 2024 | Science, Weekly Cannabis News, Weekly News
According to Associated Press this morning the FDA will move to reclassify marijuana from a Schedule I to a Schedule III drug. Schedule I drugs have a high potential for abuse and no accepted medical use, while Schedule III drugs have a lower potential for abuse and...
by Vita Maziveyi | Apr 29, 2024 | Science, Weekly News
Why We Think It’s Important: This article is important as it provides valuable insights into the acute neurocognitive effects of CannEpil, a medicinal cannabis oil, shedding light on its potential therapeutic benefits and safety profile in treating various medical...
by Stephanie Wood Miller | Apr 22, 2024 | Weekly Cannabis News, Weekly News
All the news this week points to changing attitudes toward cannabis at both the federal and state level. Cannabis seems to be one thing Americans can agree on and the hemp industry settles down after a wild ride the past few years. Three out of five Americans think...
by Vita Maziveyi | Apr 15, 2024 | Science, Weekly News
Why we think it’s important This study is important because it shows that people with cannabis use disorder have a slightly higher risk of complications and even death during major surgeries compared to those without the disorder. The findings suggest that healthcare...
by Stephanie Wood Miller | Apr 8, 2024 | Weekly Cannabis News, Weekly News
Two stories today from Marijuana Moment as state and federal officials lock horns over legalization and states’ rights. Hemp retailers face stormy waters, with calls for more regulation and evidence of inaccurate labeling. GOP urges border patrol to get tough...
